Discovery
Jacaranda takes SBIR Phase II grant for noise-induced hearing loss therapeutics
Jacaranda Bioscience, Inc., a San Francisco-based biotech, has received a USD 1.44 million SBIR Phase II award from the National Institute on Deafness and...
Curatix secures NIAID support for drug-resistant fungal infection adjuvants
The Small Business Innovation Research (SBIR) mechanism at the National Institute of Allergy and Infectious Diseases (NIAID) has awarded a USD 1.0 million...
Merakris picks up NIH grant to support MTX-001 into diabetic foot ulcer trials
Merakris Therapeutics, a Research Triangle Park, North Carolina-based clinical-stage biotechnology company, has received a Direct-to-Phase II Small Business...
EpiCure Therapeutics secures NIH grant for SLC6A1 gene therapy development
EpiCure Therapeutics, Inc., a Seattle, Washington-based Allen Institute spinout, has received a USD 1.5 million NIH R44 grant to advance an AAV gene therapy...
MSK developing machine learning models to map gene networks in RA
Memorial Sloan-Kettering Cancer Center has received a USD 1.12 million NIH supplemental award to build machine learning models of gene regulatory networks...
MD Anderson investigates Bhlhe40’s role in T cell function during immunotherapy
The University of Texas MD Anderson Cancer Center has received a USD 1.82 million National Cancer Institute R01 renewal to investigate how the transcription...
Michigan State wins NIH grant to probe high-risk autism gene ASH1L
Michigan State University has received a USD 1.03 million National Institute of Mental Health RF1 award to investigate how loss-of-function mutations in the...
Texas A&M gets renewed NIH backing for MLL-rearranged leukemia drug discovery
Texas A&M University has received a USD 1.44 million fiscal year 2026 renewal of an NIH R01 grant from the National Cancer Institute to advance a...
Atai Therapeutics wins USD 2.73m NIH grant for non-hallucinogenic psychedelic compounds in opioid disorder
atai Therapeutics has received a USD 2.73 million UG3 cooperative agreement from the National Institute on Drug Abuse to advance non-hallucinogenic...
Emory backed by NIH to push EP2 antagonist for Alzheimer's towards IND
Emory University has received a USD 1.87 million NIH U01 grant to advance an EP2 receptor antagonist toward IND-enabling studies for Alzheimer's disease,...
Sinopia Bio's PKA-II modulator demonstrates dyskinesia reduction in preclinical Parkinson's models
<a...
JAMA: Blood p-tau217 predicts cognitive impairment up to 13.5 years before Alzheimer's symptoms
Researchers at Mass General Brigham in Boston, working with collaborators across six North American cohorts, report that baseline plasma phosphorylated tau...
ARPA-H awards USD 160m to accelerate rare disease gene editing through umbrella clinical trials
ARPA-H has announced up to USD 160 million in funding over five years for seven performer teams under its THRIVE (Treating Hereditary Rare Diseases with In...
Amydis secures USD 1.1m NIH award to develop retinal imaging for TDP-43 detection
Amydis, a La Jolla, California-based diagnostics company, has received a USD 1.1 million NIH R44 Phase II SBIR award from the National Institute on Aging to...
JAX joins Broad-led consortium on USD 34.5 million ARPA-H rare disease gene-editing award
The Jackson Laboratory (JAX), in collaboration with the Broad Institute and partners across 12 institutions, has been selected for an up to USD 34.5 million...
The AllSci Brief
Free, systematic R&D and deal news. Daily.